NM-IL-12

BIOLOGICAL2 trials

Sponsors

Neumedicines Inc.

Conditions

Colostomy StomaLymphoma, Large B-Cell, Diffuse (DLBCL)

Phase 2

NM-IL-12 (rHuIL-12) in Subjects With Open Surgical Wounds

CompletedNCT02544061

Neumedicines Inc.Colostomy Stoma

Start: 2016-03-01End: 2018-02-28Updated: 2018-11-16

NM-IL-12 (rHuIL-12) In Relapsed/Refractory Diffuse Large B- Cell Lymphoma (DLBCL) Undergoing Salvage Chemotherapy

Neumedicines Inc.Lymphoma, Large B-Cell, Diffuse (DLBCL)

Start: 2016-11-30End: 2017-12-31Target: 12Updated: 2016-08-03